Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
0.1419
Dollar change
-0.0025
Percentage change
-1.73
%
Index- P/E- EPS (ttm)-2.24 Insider Own8.48% Shs Outstand22.32M Perf Week-12.62%
Market Cap3.17M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float20.43M Perf Month27.15%
Income-45.68M PEG- EPS next Q- Inst Own10.70% Short Float7.28% Perf Quarter-10.75%
Sales0.76M P/S4.17 EPS this Y- Inst Trans37.28% Short Ratio0.38 Perf Half Y-47.58%
Book/sh-0.96 P/B- EPS next Y- ROA-93.67% Short Interest1.49M Perf Year-88.91%
Cash/sh0.20 P/C0.71 EPS next 5Y- ROE-146.42% 52W Range0.10 - 1.58 Perf YTD-28.33%
Dividend Est.- P/FCF- EPS past 5Y-116.40% ROI-106.58% 52W High-91.02% Beta3.66
Dividend TTM- Quick Ratio0.28 Sales past 5Y0.00% Gross Margin-129.20% 52W Low41.76% ATR (14)0.04
Dividend Ex-Date- Current Ratio0.29 EPS Y/Y TTM-120.71% Oper. Margin-2191.12% RSI (14)45.06 Volatility10.54% 33.95%
Employees23 Debt/Eq0.36 Sales Y/Y TTM- Profit Margin-6019.47% Recom1.00 Target Price9.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-180.60% Payout- Rel Volume0.06 Prev Close0.14
Sales Surprise- EPS Surprise-50.00% Sales Q/Q- Earnings- Avg Volume3.91M Price0.14
SMA20-19.21% SMA50-3.52% SMA200-47.73% Trades Volume236,713 Change-1.73%
May-30-24 07:47AM
May-21-24 09:52AM
Feb-13-24 06:00AM
Dec-19-23 07:00AM
Dec-18-23 07:00AM
07:00AM Loading…
Nov-02-23 07:00AM
Nov-01-23 07:00AM
Oct-30-23 07:00AM
Oct-10-23 09:00AM
Aug-28-23 04:30PM
Aug-10-23 09:00AM
Aug-03-23 01:02PM
Aug-01-23 08:00AM
Jul-31-23 09:00AM
Jul-25-23 09:00AM
09:00AM Loading…
Jul-17-23 09:00AM
Jul-11-23 09:00AM
Jul-06-23 05:05PM
07:30AM
Jun-28-23 03:51PM
07:55AM
Jun-21-23 07:30AM
Jun-15-23 09:37AM
07:32AM
Jun-14-23 07:30AM
May-12-23 06:32PM
May-10-23 12:15PM
Apr-26-23 03:44PM
Apr-25-23 08:00AM
Apr-24-23 08:00AM
07:30AM Loading…
Apr-20-23 07:30AM
06:45AM
Apr-12-23 08:30AM
Apr-07-23 08:03AM
Mar-09-23 08:30AM
Feb-06-23 10:15AM
Feb-01-23 09:15AM
Jan-17-23 08:30AM
Jan-09-23 08:30AM
Dec-12-22 08:30AM
Dec-06-22 08:30AM
Dec-03-22 07:35AM
Dec-01-22 08:30AM
Nov-22-22 12:49PM
Nov-21-22 10:18AM
08:00AM
Nov-10-22 08:47AM
Nov-08-22 08:30AM
Oct-11-22 09:15AM
Sep-21-22 08:00AM
Sep-08-22 10:30AM
Aug-31-22 08:30AM
Aug-24-22 02:00PM
Aug-22-22 02:00PM
Aug-18-22 10:18AM
Aug-17-22 04:37PM
03:53PM
08:30AM
Aug-16-22 04:28PM
Aug-15-22 04:00PM
Aug-11-22 01:47PM
Aug-09-22 08:00AM
Jul-20-22 02:00PM
Jun-06-22 10:30AM
May-31-22 08:30AM
May-19-22 02:00PM
May-13-22 05:01PM
May-12-22 08:30AM
May-11-22 01:00PM
Apr-27-22 12:30PM
12:30PM
Apr-21-22 08:45AM
Apr-20-22 09:25AM
Apr-13-22 09:30AM
Apr-11-22 09:56AM
Apr-08-22 09:44AM
Apr-01-22 05:04PM
Mar-22-22 07:00AM
Feb-23-22 04:51PM
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company was founded in October 2018 and is headquartered in Cincinnati, OH.